Image of John MD

John MD

President & CEO

President & CEO at Geron Corporation

Menlo Park, California, United States

Section title

John MD's Email Addresses & Phone Numbers

John MD's Work Experience

Geron Corporation

President & CEO

2011 to Present

Menlo Park, CA



2010 to 2010

Proteolix, Inc.

President & CEO

2009 to 2010

South San Francisco, CA

John MD's Education

University of Colorado

Endocrinology & Diabetes Fellowship

1980 to 1982

Hospital of University of Pennsylvania

Internal Medicine Residency Program

1977 to 1980

University of Chicago - The Pritzker School of Medicine

MD with Honors

1973 to 1977

John MD's Professional Skills Radar Chart

Based on our findings, John MD is ...


What's on John MD's mind?

Based on our findings, John MD is ...

57% Left Brained
43% Right Brained

John MD's Estimated Salary Range

About John MD's Current Company

Geron Corporation

As President and CEO is leading Geron, a publicly traded, de-velopment stage biotechnology company after a strategic rea-lignment that has emphasized development of its first-in-class oncology drugs, and divestiture of its embryonic stem cell as-sets.

Frequently Asked Questions about John MD

What company does John MD work for?

John MD works for Geron Corporation

What is John MD's role at Geron Corporation?

John MD is President & CEO

What is John MD's personal email address?

John MD's personal email address is c****[email protected]

What is John MD's business email address?

John MD's business email address is j****[email protected]

What is John MD's Phone Number?

John MD's phone (213) ***-*141

What industry does John MD work in?

John MD works in the Biotechnology industry.

About John MD

📖 Summary

President & CEO @ As President and CEO is leading Geron, a publicly traded, de-velopment stage biotechnology company after a strategic rea-lignment that has emphasized development of its first-in-class oncology drugs, and divestiture of its embryonic stem cell as-sets. From 2011 to Present (4 years) Menlo Park, CADriver @ From 2010 to 2010 (less than a year) President & CEO @ As President and CEO led Proteolix, a biotechnology company developing proteasome inhibitors (including carfilzomib) for oncology and immunology applications, through a manage-ment realignment and subsequent merger with Onyx Pharma-ceuticals (NASDAQ: ONXX) valued at $856 million. From 2009 to 2010 (1 year) South San Francisco, CACo-Founder & CEO @ As Co-Founder and CEO, led the Company through the ac-quisition, approval and commercialization of two novel endo-crine products (INCRELEX® and SOMATULINE® DEPOT), key partnerships with Genentech and Ipsen S.A., and multiple financing rounds including the IPO in 2004 and subsequent follow-on equity offerings. Tercica merged with Ipsen in the 4th quarter of 2008 in a transaction that valued the company at approximately $660 million. From 2001 to 2008 (7 years) Brisbane, CAFounder & Director @ Developed the business plan and negotiated a joint venture with Corning, Inc., directed site selection and construction of a state-of-the-art, process development and recombinant protein cGMP manufacturing facility in RTP, and as a Director, pro-vided Board oversight for a 450 employee business with multi-ple large pharmaceutical company clients prior to its sale to Akzo Nobel’s Diosynth Division in 2001. From 1993 to 2001 (8 years) Research Triangle Park, NCFounder & CEO @ As Founder and CEO, led the Company through a key part-nership with Genentech, the acquisition, development and ap-proval of an endocrine product, SOMAVERT® (pegvisomant), and the sale of the Company to Pharmacia in 2001. From 1992 to 2001 (9 years) Austin, TXSVP, Medical and Scientific Affairs; Head, North American Clinical Development Center @ Headed up all Phase I-IV clinical development and medical af-fairs activities for pharmaceutical products and devices at NNPI, Novo Nordisk’s largest international subsidiary, and No-vo Nodisk Canada; reported to the CEO of NNPI. From 1991 to 1993 (2 years) Princeton, NJVice President, Clinical Development @ Headed up Phase I-III clinical development for a disease-modifying anti-rheumatic drug, THERAFECTIN®. From 1985 to 1990 (5 years) Greenwich, CTAdjunct Assistant Professor of Medicine @ From 1982 to 1986 (4 years) Philadelphia, PADirector, Medical Research & Services @ Responsible for Phase IIIb and Phase IV clinical programs, medical writing, pharmacovigilence, and medical affairs for McNeil’s marketed products in pain, rheumatology, psychiatry and pancreatic enzyme replacement therapy. Withdrew ZOMAX®, a leading NSAID, from the worldwide market due to serious adverse experiences, and negotiated DESI approval for PARAFON FORTE® with FDA. From 1982 to 1985 (3 years) Spring House, PAAssociate Investigator @ Studied insulin action, the pathophysiology of obesity and type II diabetes, and in vitro, in vivo and clinical effects of pharma-cologic therapies in these disorders; author or co-author of 12 peer-reviewed publications from laboratory of Jerrold Olefsky. From 1980 to 1982 (2 years) Denver, COEndocrinology & Diabetes Fellowship @ University of Colorado From 1980 to 1982 Internal Medicine Residency Program @ Hospital of University of Pennsylvania From 1977 to 1980 MD with Honors @ University of Chicago - The Pritzker School of Medicine From 1973 to 1977 BA, Chemistry @ Earlham College From 1969 to 1973

John MD’s Personal Email Address, Business Email, and Phone Number

are curated by ContactOut on this page.

10x your recruitment & sales conversations

Contact over 200M professionals
instantly by email or phone. Reveal
personal & work email addresses, as
well as phone numbers accurately with
our ContactOut Chrome extension.

In a nutshell

John MD's Personality Type

Extraversion (E), Intuition (N), Thinking (T), Judging (J)

Average Tenure

4 year(s), 2 month(s)

John MD's Willingness to Change Jobs



Open to opportunity?

There's 73% chance that John MD is seeking for new opportunities

Engage candidates 10x faster

Enjoy unlimited access and discover candidates outside of LinkedIn

Trusted by 400K users from

76% of Fortune 500 companies

Microsoft Nestle PWC JP Morgan Merck Rackspace WarnerMedia Randstad Yelp Google

The most accurate data ever

CCPA Compliant
GDPA Aligned
150M Personal Emails
300M Work Emails
50M Direct Dials
200M Professional Profiles
30M Company Profiles

Hire Anyone, Anywhere
with ContactOut today

Making remote or global hires? We can help.

  • 50 contacts/month
  • Works on standard LinkedIn only
  • Work emails, personal emails, mobile numbers
* 1 user per company limit

No credit card required

Try ContactOut for Free